Exxonmobil Investment Management Inc. TX reduced its stake in shares of Davita Inc (NYSE:DVA) by 5.4% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 34,571 shares of the company’s stock after selling 1,982 shares during the period. Exxonmobil Investment Management Inc. TX’s holdings in Davita were worth $2,350,000 at the end of the most recent quarter.
A number of other hedge funds also recently bought and sold shares of the stock. SRS Capital Advisors Inc. bought a new stake in Davita during the fourth quarter valued at $118,000. Raymond James Trust N.A. bought a new stake in Davita during the first quarter valued at $202,000. Seven Bridges Advisors LLC increased its stake in Davita by 187.1% in the third quarter. Seven Bridges Advisors LLC now owns 3,066 shares of the company’s stock valued at $203,000 after buying an additional 1,998 shares during the period. Acrospire Investment Management LLC increased its stake in Davita by 166.7% in the third quarter. Acrospire Investment Management LLC now owns 3,200 shares of the company’s stock valued at $211,000 after buying an additional 2,000 shares during the period. Finally, Ironwood Investment Management LLC increased its stake in Davita by 26.7% in the third quarter. Ironwood Investment Management LLC now owns 3,796 shares of the company’s stock valued at $251,000 after buying an additional 800 shares during the period. Hedge funds and other institutional investors own 85.31% of the company’s stock.
Davita Inc (NYSE:DVA) opened at 68.43 on Friday. The firm has a 50-day moving average of $67.93 and a 200 day moving average of $64.57. Davita Inc has a 12 month low of $54.50 and a 12 month high of $78.77. The stock has a market cap of $13.32 billion, a PE ratio of 15.95 and a beta of 1.02.
Davita (NYSE:DVA) last announced its earnings results on Thursday, February 16th. The company reported $0.98 EPS for the quarter, topping the consensus estimate of $0.91 by $0.07. Davita had a net margin of 4.92% and a return on equity of 16.16%. The company earned $3.72 billion during the quarter, compared to analysts’ expectations of $3.74 billion. During the same period last year, the company posted $1.12 earnings per share. The business’s revenue for the quarter was up 5.2% on a year-over-year basis. Analysts anticipate that Davita Inc will post $3.57 EPS for the current year.
COPYRIGHT VIOLATION NOTICE: This report was posted by Ticker Report and is the sole property of of Ticker Report. If you are accessing this report on another website, it was illegally stolen and republished in violation of international copyright laws. The correct version of this report can be read at https://www.tickerreport.com/banking-finance/2484455/exxonmobil-investment-management-inc-tx-lowers-position-in-davita-inc-dva.html.
Several analysts recently weighed in on the stock. Zacks Investment Research downgraded shares of Davita from a “buy” rating to a “hold” rating in a report on Wednesday. Royal Bank of Canada reiterated a “hold” rating and issued a $62.00 target price on shares of Davita in a report on Friday, February 17th. Finally, TheStreet upgraded shares of Davita from a “c+” rating to a “b-” rating in a report on Monday, April 3rd. Seven equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. The stock presently has an average rating of “Hold” and an average price target of $70.33.
DaVita Inc, formerly DaVita HealthCare Partners Inc, operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support.
Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Davita Inc (NYSE:DVA).
Receive News & Ratings for Davita Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita Inc and related companies with MarketBeat.com's FREE daily email newsletter.